Join The Discussion

 

Obama calls for offshore drilling in Southeast

WASHINGTON — The Obama administration on Tuesday outlined a politically fraught plan for allowing oil and gas drilling offshore along parts of the Atlantic coast while imposing new restrictions on environmentally fragile waters off northern Alaska.

read more >

Alliance's Hillwood Commons lands first tenant

A large title insurance, property valuation and settlement services company is the first tenant at Hillwood Commons I, an office complex at Alliance Town Center.

read more >

Museum District: Area’s evolution creating more interaction, public spaces

Fifteen years ago if someone had shot a cannon from Fort Worth’s world-renowned museum district, nobody would have noticed, joked Lori Eklund, senior deputy director of the Amon Carter Museum of American Art. But that has changed.

read more >

Energy Transfer Partners, Regency Energy announce $18B merger

Energy Transfer Partners LP of Dallas and Regency Energy Partners LP have entered into a definitive merger agreement.

read more >

American Airlines' first 787 Dreamliner arrives at D/FW

American is preparing the plane to begin service sometime in the second quarter.

read more >

 

TECH Fort Worth client receives $550,000 financing

 

Betty Dillard

bdillard@bizpress.net

Vital Art and Science Inc. (VAS), creator of the myVisionTrack home vision monitor, has completed a $550,000 Series A round of financing, the Richardson-based company announced Aug. 27.


The funding will enable VAS to continue development of its smart phone-based home monitor products and support its work with strategic partners to bring the myVisionTrack test to millions of patients around the world.
The funding round was led by the North Texas Angel Network (NTAN), and valued the company at $10 million post financing.


“The myVisionTrack home monitor is the first easy-to-use and accurate test for patients already diagnosed with a wet-AMD, or diabetic retinopathy, to monitor their disease progress and help ensure they get timely treatments to help save their vision,” said Mike Bartlett, VAS founder and president.


Bartlett said the company received its clearance from the U.S. Food and Drug Administration in February. The funding will allow VAS, a client of technology incubator TECH Fort Worth, to bring its product to market.
MyVisionTrack can be used in a physician’s office or at home by patients with these diseases to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects.
 

< back

Email   email
hide
Catch
How 'bout them Cowboys?